封面
市場調查報告書
商品編碼
1605712

鋅指核酸酶技術市場,按技術平台、交付方式、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Zinc Finger Nuclease Technology Market, By Technology Platform, By Delivery Method, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: | 出版商: AnalystView Market Insights | 英文 356 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年鋅指核酸酶技術市場規模為7.44億美元,2024年至2032年複合年成長率為21.5%。

鋅指核酸酶技術市場-市場動態

政府對基因編輯計畫的支持推動鋅指核酸酶技術市場的成長

政府措施顯著促進了鋅指核酸酶 (ZFN) 技術市場的成長。例如,美國國立衛生研究院 (NIH) 已為基因編輯計畫分配了大量資金,包括使用 ZFN 技術進行精準醫療和農業應用的計畫。 2021年,NIH投資1.9億美元用於基因編輯研究,促進治療性基因編輯領域的創新。此外,歐盟的 Horizo​​​​n 2020 計劃還支持各種基於 ZFN 的臨床試驗。隨著全球各國政府認知到基因編輯技術(包括 ZFN)的變革潛力,投資的增加和優惠政策正在推動從醫療保健到農業等行業的採用。監管環境也有所改善,FDA 和 EMA 等機構致力於制定更明確的基因編輯療法指南,為 ZFN 市場擴張創造有利的環境。此外,生物技術公司、研究機構和政府機構之間的合作持續加強ZFN在遺傳疾病和基因改造作物方面的應用。

鋅指核酸酶技術市場 - 關鍵見解

根據我們的研究分析師分享的分析,預計全球市場在預測期內(2024-2032 年)每年將以 21.5% 左右的複合年成長率成長

根據技術平台細分,預計模組化組裝將在 2023 年顯示出最大的市場佔有率

根據交付方式細分,2023 年 In Vivo 是領先類型

按地區分類,北美是 2023 年的主要收入來源

鋅指核酸酶技術市場-細分分析:

全球鋅指核酸酶技術市場根據技術平台、交付方法、最終用戶和地區進行細分。

根據技術平台,市場分為兩類:模組化組裝和OPEN(低聚池工程)。由於其在設計基因編輯工具方面的靈活性和效率,模組化組裝技術平台預計將引領鋅指核酸酶技術市場。隨後推出了 OPEN(寡聚庫工程),為特定應用提供有針對性的精確基因編輯功能。

根據交付方式,市場分為兩類:體內和體外。體內遞送方法預計將引領鋅指核酸酶技術市場,因為它直接應用於活體生物體,可以更有效地進行基因編輯。 Ex Vivo緊隨其後,在重新引入生物體之前對生物體外的細胞進行有針對性的編輯。

鋅指核酸酶技術市場-地理洞察

北美是鋅指核酸酶 (ZFN) 技術市場的領先地區,這主要歸功於政府的大力支持、先進的醫療基礎設施和強勁的生物技術產業成長。 2022 年,美國政府為基因編輯計畫撥款超過 5 億美元,推動 ZFN 技術在各種醫療應用中的採用,例如罕見疾病的基因療法。該地區還擁有 Sangamo Therapeutics 等大型生物技術公司,該公司正在積極推進針對遺傳性疾病的基於 ZFN 的基因編輯治療,正在進行臨床試驗並與加州大學等機構合作。此外,美國 FDA 簡化基因編輯產品核准流程的舉措為 ZFN 技術的採用創造了有利的監管環境。歐洲緊跟著英國和德國等國家的腳步,這些國家越來越關注基因編輯研究,領先機構和生技公司之間的合作證明了這一點。此外,由於中國和印度等國家研究投資的增加和生物技術生態系統的不斷發展,亞太地區正在成為一個充滿前景的市場。

鋅指核酸酶技術市場-競爭格局:

鋅指核酸酶 (ZFN) 技術市場的競爭格局主要由北美公司主導,Sangamo Therapeutics 和 Precision Biosciences 等主要參與者處於領先地位。 Sangamo Therapeutics 總部位於美國,因其持續努力開發基於 ZFN 的遺傳性疾病療法而受到認可,包括與輝瑞合作推進血友病基因療法。 2022年,Sangamo與賽諾菲建立策略夥伴關係,開發基於ZFN的自體免疫疾病治療方法,反映出對ZFN技術日益成長的信心。另一個著名的公司 Precision Biosciences 在使用 ZFN 技術解決鐮狀細胞疾病等各種遺傳疾病的臨床試驗中取得了長足進展。在歐洲,顯著的進展包括生技公司和學術機構之間的合作,以完善 ZFN 應用。同時,在亞太地區,中國不斷崛起的生物技術生態系統正在推動市場動態的轉變,當地公司在政府支持的研究計畫的支持下,擴大關注基因編輯技術,包括 ZFN。

最新進展:

2024 年 5 月,廣島大學和日本國家先進產業科學研究所的研究人員使用機器學習驅動的模組化組裝系統增強了鋅指核酸酶 (ZFN) 技術。這項進步提高了基因編輯效率,為治療遺傳性疾病提供了一個有前景的工具。

目錄

第1章:鋅指核酸酶技術市場概述

  • 研究範圍
  • 市場預估年份

第 2 章:執行摘要

  • 市場片段
    • 鋅指核酸酶技術市場片段(依技術平台)
    • 鋅指核酸酶技術市場片段(以交付方式)
    • 最終用戶的鋅指核酸酶技術市場片段
    • 鋅指核酸酶技術市場片段(依國家)
    • 按地區分類的鋅指核酸技術市場片段
  • 競爭洞察

第 3 章:鋅指核酸酶技術主要市場趨勢

  • 鋅指核酸酶技術市場促進因素
    • 市場促進因素的影響分析
  • 鋅指核酸酶技術市場限制
    • 市場限制影響分析
  • 鋅指核酸酶技術的市場機會
  • 鋅指核酸酶技術市場未來趨勢

第 4 章:鋅指核酸酶技術產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章:鋅指核酸酶技術市場:COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章:鋅指核酸酶技術市場格局

  • 2023 年鋅指核酸酶技術市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章:鋅指核酸酶技術市場 - 依技術平台

  • 概述
    • 按技術平台分類的細分市場佔有率分析
    • 模組化組裝
    • OPEN(低聚池工程)

第 8 章:鋅指核酸酶技術市場 - 依交付方式

  • 概述
    • 按交付方式分類的細分市場佔有率分析
    • 體內
    • 離體

第 9 章:鋅指核酸酶技術市場 - 依最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 製藥與生物技術公司
    • 學術研究機構
    • 合約研究組織

第 10 章:鋅指核酸酶技術市場 - 依地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 鋅指核酸酶技術北美主要製造商
    • 北美市場規模和預測(按國家)
    • 北美市場規模與預測(按技術平台)
    • 北美市場規模和預測(按交付方式)
    • 北美市場規模和預測(按最終用戶)
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲鋅指核酸酶技術主要製造商
    • 歐洲市場規模和預測(按國家)
    • 歐洲市場規模與預測(按技術平台)
    • 歐洲市場規模和預測(按交付方式)
    • 歐洲市場規模和預測(按最終用戶)
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 鋅指核酸酶技術亞太區主要廠商
    • 亞太地區市場規模與預測(按國家)
    • 按技術平台分類的亞太市場規模與預測
    • 亞太地區市場規模與預測(以交付方式)
    • 亞太地區市場規模和預測(按最終用戶)
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 鋅指核酸酶技術拉丁美洲主要製造商
    • 拉丁美洲市場規模與預測(按國家)
    • 拉丁美洲市場規模與預測(按技術平台)
    • 拉丁美洲市場規模和預測(以交付方式)
    • 拉丁美洲市場規模和預測(按最終用戶)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 鋅指核酸酶技術中東和非洲主要生產商
    • 中東和非洲市場規模及預測(按國家)
    • 中東和非洲市場規模及預測(按技術平台)
    • 中東和非洲市場規模及預測(以交付方式)
    • 中東和非洲市場規模和預測(按最終用戶)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第11章:主要供應商分析-鋅指核酸酶技術產業

  • 競爭儀表板
  • 公司簡介
    • Agenus Inc.
    • Amgen Inc.
    • Beam Therapeutics Inc.
    • Bluebird Bio, Inc.
    • CRISPR Therapeutics AG
    • Editas Medicine, Inc.
    • GenScript Biotech Corporation
    • Horizon Discovery Group plc
    • Intellia Therapeutics, Inc.
    • Lonza Group AG
    • Novartis AG
    • Poseida Therapeutics, Inc.
    • Precision BioSciences, Inc.
    • Sangamo Therapeutics, Inc.
    • Sigma-Aldrich Corporation
    • Thermo Fisher Scientific Inc.
    • Others

第 12 章:360 度分析師視角

第 13 章:附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4337

REPORT HIGHLIGHT

The Zinc Finger Nuclease Technology Market size was valued at USD 744 Million in 2023, expanding at a CAGR of 21.5% from 2024 to 2032.

The Zinc Finger Nuclease (ZFN) technology market focuses on the development and application of highly specific gene-editing tools used for targeted DNA modification. ZFNs are used in a variety of research and therapeutic applications, including gene therapy, crop development, and disease modeling. As the potential of gene editing becomes increasingly recognized, the demand for precise, reliable, and efficient gene-editing tools has grown. According to a report from the National Institutes of Health, ZFN technology is being explored for its potential to correct genetic defects, especially in rare genetic disorders. The market benefits from advancements in biotechnology, as ZFNs offer a high degree of specificity, reducing off-target effects compared to other gene-editing technologies like CRISPR. However, high development costs and regulatory hurdles related to the use of ZFNs in human therapy pose challenges. Despite this, ongoing research, collaborations between biotech firms, and government support for gene-editing initiatives are opening up substantial market opportunities in healthcare, agriculture, and environmental sustainability.

Zinc Finger Nuclease Technology Market- Market Dynamics

Government Support for Gene-Editing Initiatives Drives Growth in the Zinc Finger Nuclease Technology Market

Government initiatives are significantly boosting the growth of the Zinc Finger Nuclease (ZFN) technology market. For instance, the U.S. National Institutes of Health (NIH) has allocated substantial funding for gene-editing projects, including those using ZFN technology for precision medicine and agricultural applications. In 2021, the NIH invested $190 million in gene-editing research, fostering innovation in therapeutic gene editing. Additionally, the European Union's Horizon 2020 program has supported various ZFN-based clinical trials. As governments globally acknowledge the transformative potential of gene-editing technologies, including ZFN, increased investments and favorable policies are driving adoption in industries ranging from healthcare to agriculture. The regulatory environment has also improved, with agencies such as the FDA and EMA working on clearer guidelines for gene-editing therapies, creating a conducive environment for ZFN market expansion. Furthermore, collaborations between biotech firms, research institutes, and governmental bodies continue to enhance the application of ZFN in genetic diseases and genetically modified crops.

Zinc Finger Nuclease Technology Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 21.5% over the forecast period (2024-2032)

Based on Technology Platform segmentation, Modular Assembly was predicted to show maximum market share in the year 2023

Based on Delivery Method segmentation, In Vivo was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Zinc Finger Nuclease Technology Market- Segmentation Analysis:

The Global Zinc Finger Nuclease Technology Market is segmented on the basis of Technology Platform, Delivery Method, End-User, and Region.

The market is divided into two categories based on Technology Platform: Modular Assembly and OPEN (Oligomerized Pool Engineering). The Modular Assembly technology platform is expected to lead the Zinc Finger Nuclease Technology market due to its flexibility and efficiency in designing gene-editing tools. OPEN (Oligomerized Pool Engineering) follows, offering targeted and precise gene-editing capabilities for specific applications.

The market is divided into two categories based on the Delivery Method: In Vivo and Ex Vivo. In Vivo delivery method is anticipated to lead the Zinc Finger Nuclease Technology market, owing to its direct application in living organisms, allowing for more efficient gene editing. Ex Vivo follows, offering targeted editing in cells outside the organism before reintroduction.

Zinc Finger Nuclease Technology Market- Geographical Insights

North America is the leading region in the Zinc Finger Nuclease (ZFN) technology market, primarily due to significant government support, advanced healthcare infrastructure, and robust biotech industry growth. In 2022, the U.S. government allocated over $500 million in funding for gene-editing initiatives, contributing to the adoption of ZFN technology in various medical applications, such as gene therapies for rare diseases. The region also boasts major biotech companies like Sangamo Therapeutics, which is actively advancing ZFN-based gene-editing treatments for genetic disorders, with ongoing clinical trials and collaborations with institutions like the University of California. Additionally, the U.S. FDA's initiatives to streamline approval processes for gene-editing products have created a favorable regulatory environment for ZFN technology adoption. Europe follows closely with countries like the UK and Germany, which are increasingly focusing on gene-editing research, evidenced by collaborations between leading institutions and biotech companies. Furthermore, Asia-Pacific is emerging as a promising market due to increased research investments and a growing biotech ecosystem in countries like China and India.

Zinc Finger Nuclease Technology Market- Competitive Landscape:

The competitive landscape of the Zinc Finger Nuclease (ZFN) technology market is largely dominated by North American companies, with key players like Sangamo Therapeutics and Precision Biosciences leading the charge. Sangamo Therapeutics, headquartered in the U.S., is recognized for its ongoing efforts to develop ZFN-based therapies for genetic disorders, including its collaboration with Pfizer to advance gene therapies for hemophilia. In 2022, Sangamo entered into a strategic partnership with Sanofi to develop ZFN-based treatments for autoimmune diseases, reflecting the growing confidence in ZFN technology. Another notable player, Precision Biosciences, has made strides in clinical trials using ZFN technology to address various genetic conditions, such as sickle cell disease. In Europe, notable developments include collaborations between biotech firms and academic institutions to refine ZFN applications. Meanwhile, in the Asia-Pacific region, China's rising biotech ecosystem is contributing to a shift in the market dynamics, with local companies increasing their focus on gene-editing technologies, including ZFNs, supported by government-backed research initiatives.

Recent Developments:

In May 2024, Researchers from Hiroshima University and the Japanese National Institute of Advanced Industrial Science enhanced Zinc Finger Nuclease (ZFN) technology using machine learning-driven modular assembly systems. This advancement improves gene editing efficiency, offering a promising tool for treating genetic disorders.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Agenus Inc.
  • Amgen Inc.
  • Beam Therapeutics Inc.
  • Bluebird Bio, Inc.
  • CRISPR Therapeutics AG
  • Editas Medicine, Inc.
  • GenScript Biotech Corporation
  • Horizon Discovery Group plc
  • Intellia Therapeutics, Inc.
  • Lonza Group AG
  • Novartis AG
  • Poseida Therapeutics, Inc.
  • Precision BioSciences, Inc.
  • Sangamo Therapeutics, Inc.
  • Sigma-Aldrich Corporation
  • Thermo Fisher Scientific Inc.
  • Others

GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET, BY TECHNOLOGY PLATFORM- MARKET ANALYSIS, 2019 - 2032

  • Modular Assembly
  • OPEN (Oligomerized Pool Engineering)

GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET, BY DELIVERY METHOD- MARKET ANALYSIS, 2019 - 2032

  • In Vivo
  • Ex Vivo

GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical & Biotechnology Companies
  • Academic Research Institutes
  • CROs

GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Zinc Finger Nuclease Technology Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Zinc Finger Nuclease Technology Market Snippet by Technology Platform
    • 2.1.2. Zinc Finger Nuclease Technology Market Snippet by Delivery Method
    • 2.1.3. Zinc Finger Nuclease Technology Market Snippet by End-User
    • 2.1.4. Zinc Finger Nuclease Technology Market Snippet by Country
    • 2.1.5. Zinc Finger Nuclease Technology Market Snippet by Region
  • 2.2. Competitive Insights

3. Zinc Finger Nuclease Technology Key Market Trends

  • 3.1. Zinc Finger Nuclease Technology Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Zinc Finger Nuclease Technology Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Zinc Finger Nuclease Technology Market Opportunities
  • 3.4. Zinc Finger Nuclease Technology Market Future Trends

4. Zinc Finger Nuclease Technology Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Zinc Finger Nuclease Technology Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Zinc Finger Nuclease Technology Market Landscape

  • 6.1. Zinc Finger Nuclease Technology Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Zinc Finger Nuclease Technology Market - By Technology Platform

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology Platform, 2023 & 2032 (%)
    • 7.1.2. Modular Assembly
    • 7.1.3. OPEN (Oligomerized Pool Engineering)

8. Zinc Finger Nuclease Technology Market - By Delivery Method

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Delivery Method, 2023 & 2032 (%)
    • 8.1.2. In Vivo
    • 8.1.3. Ex Vivo

9. Zinc Finger Nuclease Technology Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2. Pharmaceutical & Biotechnology Companies
    • 9.1.3. Academic Research Institutes
    • 9.1.4. CROs

10. Zinc Finger Nuclease Technology Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Zinc Finger Nuclease Technology Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Zinc Finger Nuclease Technology Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Zinc Finger Nuclease Technology Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Zinc Finger Nuclease Technology Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Zinc Finger Nuclease Technology Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Zinc Finger Nuclease Technology Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Agenus Inc.
    • 11.2.2. Amgen Inc.
    • 11.2.3. Beam Therapeutics Inc.
    • 11.2.4. Bluebird Bio, Inc.
    • 11.2.5. CRISPR Therapeutics AG
    • 11.2.6. Editas Medicine, Inc.
    • 11.2.7. GenScript Biotech Corporation
    • 11.2.8. Horizon Discovery Group plc
    • 11.2.9. Intellia Therapeutics, Inc.
    • 11.2.10. Lonza Group AG
    • 11.2.11. Novartis AG
    • 11.2.12. Poseida Therapeutics, Inc.
    • 11.2.13. Precision BioSciences, Inc.
    • 11.2.14. Sangamo Therapeutics, Inc.
    • 11.2.15. Sigma-Aldrich Corporation
    • 11.2.16. Thermo Fisher Scientific Inc.
    • 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us